The Barrow Neurological Institute has expanded its Barrow Neuroanalysis Center, nearly doubling dedicated research space to more than 18,000 square feet and bringing additional research programs into one location. The center expansion will add 8,317 square feet to the existing 10,099 square foot facility and will be located at Park Central in the Phoenix Medical Quarter.
This expansion is important for neurological research. This will accelerate our ability to uncover further insights into environmental factors and healthcare access associated with neurological diseases, ultimately leading to efforts to reduce disparities and disease burden. ”
Brad Russett, MD, FAAN, Chairman and Senior Vice President of Neurology, Barrow Neurological Institute
Founded in 2024, the Barrow Neuroanalysis Center has quickly established itself as a pioneer in neurological research. The center’s team of researchers is world-renowned for groundbreaking environmental research, world-class neuroscience, and AI research. Researchers at the center use data-focused methods to study Parkinson’s disease, Alzheimer’s disease, stroke, ALS, and brain tumors.
“The research conducted at the Barrow Center for Neuroanalysis is important for developing new treatments and finding answers to intractable neurological diseases. It will also help shape global environmental policy to reduce the burden of disease,” says Dr. Racette.
